---
id: easl-decompensated-cirrhosis-2018
title: "EASL Clinical Practice Guidelines for the Management of Patients with Decompensated Cirrhosis"
short_title: "EASL Decompensated Cirrhosis 2018"

organization: European Association for the Study of the Liver
collaborators: null
country: null
url: https://www.journal-of-hepatology.eu/article/S0168-8278(18)31966-4/fulltext
doi: 10.1016/j.jhep.2018.03.024
pmid: 29653741
open_access: true

specialty: gastroenterology
guideline_type: clinical-practice
evidence_system: other
conditions:
  - decompensated cirrhosis
  - liver cirrhosis
  - ascites
  - encephalopathy
tags:
  - complications of cirrhosis
  - SBP
  - HRS
  - variceal bleeding

publication_date: 2018-04-01
previous_version_date: null
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-22
---

# EASL Clinical Practice Guidelines for the Management of Patients with Decompensated Cirrhosis

## Scope
First comprehensive EASL guidelines on management of decompensated cirrhosis, covering ascites, hepatic encephalopathy, variceal bleeding, infections, and other complications.

## Key Recommendations

### Ascites Management

#### Initial Treatment
- **Sodium restriction**: 80-120 mmol/day (4.6-6.9 g salt/day)
- **Diuretics**: Spironolactone (starting 100mg/day, max 400mg) + furosemide (starting 40mg/day, max 160mg)
- Weight loss goal: 0.5 kg/day without edema, 1 kg/day with edema

#### Refractory Ascites
- **Large volume paracentesis (LVP)** with albumin replacement (8g per liter removed if >5L)
- **TIPS**: Consider for recurrent LVP, if no contraindications
- Avoid NSAIDs (precipitate renal failure)

### Hepatic Encephalopathy

#### Treatment
- **Lactulose**: First-line, titrate to 2-3 soft stools daily
- **Rifaximin**: Add for recurrent HE despite lactulose
- Identify and treat precipitants (infection, GI bleeding, constipation, medications)

#### Prevention
- Lactulose for secondary prophylaxis after first episode
- Rifaximin add-on for recurrent episodes

### Variceal Bleeding

#### Acute Management
- **Vasoactive drugs**: Terlipressin, somatostatin, or octreotide for 2-5 days
- **Endoscopic variceal ligation (EVL)**: Within 12 hours
- **Antibiotics**: Ceftriaxone 1g/day IV (or quinolone) for 7 days
- **Restrictive transfusion**: Target Hb 7-8 g/dL

#### Prevention
- **Primary prophylaxis**: Non-selective beta-blockers or EVL for large varices
- **Secondary prophylaxis**: Combination of NSBB + EVL

### Bacterial Infections

#### Spontaneous Bacterial Peritonitis (SBP)
- **Diagnosis**: Ascitic fluid PMN ≥250 cells/mm³
- **Treatment**: Third-generation cephalosporin (cefotaxime 2g q8h) for 5-7 days
- **Albumin**: 1.5 g/kg day 1, 1 g/kg day 3 (reduces mortality/renal failure)
- **Prophylaxis**: Norfloxacin 400mg/day for high-risk patients

### Hepatorenal Syndrome

#### HRS-AKI (Type 1)
- Stop diuretics, expand volume with albumin
- **Terlipressin + albumin**: First-line treatment
- **Norepinephrine + albumin**: Alternative if terlipressin unavailable
- Consider TIPS or liver transplant evaluation

### Acute-on-Chronic Liver Failure (ACLF)
- See EASL ACLF Guideline 2023 for detailed management

## General Principles
- Early liver transplant evaluation for all decompensated patients
- Manage nutritional deficiencies
- Avoid nephrotoxic drugs (NSAIDs, aminoglycosides, contrast)
- Prompt recognition and treatment of infections
